CONCURRENT TECHNOLOGIES PLC – Notice Of Results And Investor Presentation
RNS Number : 0353O Concurrent Technologies PLC 28 July 2026 28 July 2026 Concurrent Technologies Plc (the “Company” or
RNS Number : 0353O Concurrent Technologies PLC 28 July 2026 28 July 2026 Concurrent Technologies Plc (the “Company” or
RNS Number : 8670M Concurrent Technologies PLC 20 July 2026 20 July 2026 Concurrent Technologies Plc (“Concurrent”, the
RNS Number : 9762L Concurrent Technologies PLC 13 July 2026 This announcement contains inside information as stipulated under the
RNS Number : 6830K Concurrent Technologies PLC 02 July 2026 2 July 2026 Concurrent Technologies Plc (“Concurrent”, the “Company”
RNS Number : 5082Y Concurrent Technologies PLC 30 March 2026 30 March 2026 Concurrent Technologies Plc (the “Company” or
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce positive data from its pharmacokinetic (“PK”) study FM58 of MED2002, the Company’s topical gel for erectile dysfunction (“ED”). MED2002 contains glyceryl trinitrate (“GTN”) as its active ingredient.
Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, is pleased to announce a new processor board.
Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, announces results for the year to 31 December 2018.
Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, is pleased to announce a new rugged server board.
Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, is pleased to announce a new CompactPCI® computing board.